NLS Pharmaceutics Ltd. - Warrant (NLSPW)

Last Price0.0218

Change+0.0061 (38.85%)

NASDAQ · Last Trade: Oct 8th, 3:19 AM EDT

NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letterbenzinga.com

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) recently released a comprehensive shareholder letter by its CEO, Alex Zwyer, detailing recent achievements and ongoing endeavors.

Via Benzinga · August 28, 2023